Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection
Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)
DOI: 10.1128/aac.00467-26 ↗Kurz gefasst
Kommentar in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Simone Giuliano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Burkholderia cenocepacia, Burkholderia Infections, Cephalosporins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this issue, B. Gaglani, T. M. Andermann, C. Wate, J. Oldan, et al. (Antimicrob Agents Chemother 70:e01542-25, 2026, https://doi.org/10.1128/aac.01542-25 ) describe a recurrent Burkholderia cenocepacia infection successfully treated with cefiderocol plus sulbactam-durlobactam. Treatment decisions are often made with incomplete microbiological and pharmacological data, even as interest in mechanism-based β-lactam combination strategies continues to grow. This case supports the utility of cefiderocol plus sulbactam-durlobactam in B. cenocepacia infection and reinforces the importance of multidisciplinary approaches to better estimate the risk of treatment failure and optimize antimicrobial therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
- Department of Diagnostic and Public Health, Microbiology Section, Verona University, Verona, Italy.
- Microbiology and Virology Unit, Department of Pathology, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.
- Department of Medicine, DMED University of Udine, Udine, Italy.
ORCID-Profile: Paolo Gaibani, Carlo Tascini
Zitieren
APA
Giuliano, S., Gaibani, P., & Tascini, C. (2026). Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00467-26
Vancouver
Giuliano S, Gaibani P, Tascini C. Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00467-26
BibTeX
@article{Giuliano2026,
author = {Giuliano, Simone and Gaibani, Paolo and Tascini, Carlo},
title = {Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {7},
doi = {10.1128/aac.00467-26}
}
EUVIMED